Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 4, April, p. 515–523

doi: 10.17219/acem/68741

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The influence of gender on selected risk factors for chronic non-communicable diseases in patients hospitalized in surgical wards: A cross-sectional study

Aleksandra Kołtuniuk1,A,B,C,D,E, Joanna Rosińczuk1,A,E,F

1 Department of Nervous System Diseases, Faculty of Health Science, Wroclaw Medical University, Poland

Abstract

Background. Chronic non-communicable diseases (CNCDs) are the leading cause of mortality in the world. Identification of risk factors and the implementation of preventive measures can effectively reduce the chance of disease and death due to CNCDs.
Objectives. The aim of this study was to analyze selected risk factors of CNCDs in women and men hospitalized in surgical wards.
Material and Methods. The study group included 420 patients aged 18–84 years who were hospitalized in surgical wards. All participants were interviewed prior to anthropometric measurements, blood pressure, and fasting blood tests. A statistical analysis of the material was performed with the use of Student’s t-test, χ2 test, Fisher’s exact test, Mann-Whitney U test, and analysis of variance (ANOVA).
Results. The analysis of the study material showed abdominal obesity in 63% of patients, more likely in women (p < 0.001); increased total cholesterol values in 30% of patients, more frequently in women (p = 0.025); blood pressure values ≥140/90 mm Hg in 28% of patients, more frequently in men (p < 0.001); alcohol abuse (≥5 points in the Michigan Alcoholism Screening Test, MAST) in 12.6% of patients, more frequently in men (p < 0.001).
Conclusion. Both women and men are at risk of developing CNCDs; however, women should pay more attention to psychological counseling and the prevention of obesity and hypercholesterolemia, while men should be educated on how to prevent hypertension and alcohol abuse.

Key words

obesity, risk factors, cardiovascular diseases, smoking, diabetes mellitus type 2

References (78)

  1. Global status report on noncommunicable diseases. Geneva: WHO; 2014.
  2. Leading causes of death in Europe: Fact sheet 2012. Copenhagen: WHO Regional Office for Europe; 2012. http://www.who.int/mediacentre/factsheets/fs310_2008.pdf. Accessed July 27, 2015.
  3. Rocznik demograficzny 2014. Warszawa: GUS; 2014.
  4. Sixty-fifth World Health Assembly, second report of Committee A. A65/54. Genewa: WHO; 2012.
  5. Biernat E, Stupnicki R, Gajewski A. Międzynarodowy Kwestionariusz Aktywności Fizycznej (IPAQ) – wersja polska. WFIZ. 2007;51(1):47–54.
  6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
  7. Ciborowska H, Rudnicka A. Żywienie zdrowego i chorego człowieka. Warszawa: PZWL; 2014.
  8. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119–1127.
  9. Selzer ML. The Michigan alcoholism screening test: The quest for a new diagnostic instrument. Am J Psychiatry. 1971;127:1653–1658.
  10. Juczyński Z, Ogińska-Bulik. Narzędzia pomiaru stresu i radzenia sobie ze stresem. Warszawa: Pracownia Testów Psychologicznych; 2009.
  11. Levy ML, Fletcher M, Price DB, Hausend T, Halbert RJ, Yawn BP. International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care. Prim Care Respir J. 2006;15:20–34. doi:10.1016/j.pcrj.2005.10.004
  12. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24:987–1003.
  13. Widecka K, Grodzicki T, Narkiewicz K, Tykarska A, Dziwura J. Zasady postępowania w nadciśnieniu tętniczym – 2011 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadciśn Tętn. 2011;11:55–82.
  14. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–1701. doi:10.1093/eurheartj/ehs092
  15. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2014. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol Klin. 2014;3(Suppl A):1–72.
  16. Section 3: Guide to Physical Measurements (Step 2). Available from: www.who.int/entity/chp/steps/Part3_Section3.pdf. Accessed July 27, 2015
  17. Alberti K, Zimmet PZ, Shaw J, Grundy SM. The IDF consensus worldwide definition of metabolic syndrome. Brussels, Belgium, International Diabetes Federation; 2006 Available from: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome. Accessed July 25, 2015.
  18. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet. 2010;376:112–123. doi:10.1016/S0140–6736(10)60834–3
  19. Blomstrand A, Blomstrand C, Ariai N, Bengtsson C, Björkelund C. Stroke incidence and association with risk factors in women: A 32-year follow-up of the Prospective Population Study of Women in Gothenburg. BMJ Open. 2014;4:e005173. doi:10.1136/bmjopen-2014–005173
  20. Islami F, Mańczuk M, Vedanthan R, et al. A cross-sectional study of cardiovascular disease and associated factors. Ann Agric Environ Med. 2011;18:255–259.
  21. Sun G-Z, Li Z, Guo L, Zhou Y, Yang H-M, Sun Y-X. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults. Lipids Health Dis. 2014;13:189. doi:10.1186/1476–511X-13–189
  22. Nahhas GJ, Daguise V, Ortaglia A, Merchant AT. Determinants of major cardiovascular risk factors among participants of the South Carolina WISEWOMAN program, 2009–2012. Prev Chronic Dis. 2014;11:E153. doi:10.5888/pcd11.140044
  23. Amiri M, Majid H, Hairi F, Thangiah N, Bulgiba A, Su T. Prevalence and determinants of cardiovascular disease risk factors among the residents of urban community housing projects in Malaysia. BMC Public Health. 2014;14:S3. doi:10.1186/1471–2458–14-S3-S3
  24. Salas R, Bibiloni M del M, Ramos E, et al. Metabolic syndrome prevalence among northern Mexican adult population. PLoS One. 2014;9:e105581. doi:10.1371/journal.pone.0105581
  25. Luksiene D, Tamosiunas A, Baceviciene M, et al. Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45–64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors. PLoS One. 2014;9:e100158. doi:10.1371/journal.pone.0100158
  26. Dhungana RR, Devkota S, Khanal MK, et al. Prevalence of cardiovascular health risk behaviors in a remote rural community of Sindhuli district, Nepal. BMC Cardiovasc Disord. 2014;14:92. doi:10.1186/1471–2261–14–92
  27. Pilav A, Brankovic S, Doder V. Ten year trends in cardiovascular risk factors in the Federation of Bosnia and Herzegovina. Med Arch. 2014;68:394–398. doi:10.5455/medarh.2014.68.394–398
  28. Solbraa AK, Holme IM, Graff-Iversen S, Resaland GK, Aadland E, Anderssen SA. Physical activity and cardiovascular risk factors in a 40- to 42-year-old rural Norwegian population from 1975–2010: Repeated cross-sectional surveys. BMC Public Health. 2014;14:569. doi:10.1186/1471–2458–14–569
  29. Sangaleti C, Trincaus M, Baratieri T, et al. Prevalence of cardiovascular risk factors among truck drivers in the South of Brazil. BMC Public Health. 2014;14:1063. doi:10.1186/1471–2458–14–1063
  30. Tárraga López PJ, Garcia-Norro Herreros FJ, Tárraga Marcos L, et al. Intervención activa en la hipercolesterolemia de pacientes con riesgo cardiovascular alto de Atención Primaria; estudio ESPROCOL. Nutr Hosp. 2015;31:2261–2268. doi:10.3305/nh.2015.31.5.8795
  31. Sugiyama D, Okamura T, Watanabe M, et al. Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study. J Atheroscler Thromb. 2015;22:95–107. doi:10.5551/jat.25908
  32. AL-Nooh AA, Abdulabbas Abdulla Alajmi A, Wood D. The Prevalence of cardiovascular disease risk factors among employees in the Kingdom of Bahrain between October 2010 and March 2011: A cross-sectional study from a Workplace Health Campaign. Cardiol Res Pract. 2014;2014:1–9. doi:10.1155/2014/832421
  33. Zaman F, Borang A. Prevalence of diabetes mellitus amongst rural hilly population of North Eastern India and its relationship with associated risk factors and related co-morbidities. J Nat Sci Biol Med. 2014;5:383. doi:10.4103/0976–9668.136195
  34. Teramoto M, Moonie S, Cross CL, Chino M, Alpert PT. Association of leisure-time physical activity to cardiovascular disease prevalence in relation to smoking among adult Nevadans. PloS One. 2015;10:e0128424. doi:10.1371/journal.pone.0128424
  35. Sepehri A, Palazón-Bru A, Gil-Guillén VF, et al. Diabetes screening: A pending issue in hypertense/obese patients. Peer J. 2015;3:e914. doi:10.7717/peerj.914
  36. Ghassibe-Sabbagh M, Deeb M, Salloum AK, et al. Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population. Diabetol Metab Syndr. 2014;6:89. doi:10.1186/1758–5996–6-89
  37. Zatońska K, Ilow R, Regulska-Ilow B, et al. Prevalence of diabetes mellitus and IFG in the prospective cohort “PONS” study – Baseline assessment. Ann Agric Environ Med. 2011;18:265–269.
  38. Rutkowski M, Bandosz P, Czupryniak L, et al. Prevalence of diabetes and impaired fasting glucose in Poland-the NATPOL 2011 Study. Diabet Med J Br Diabet Assoc. 2014;31:1568–1571. doi:10.1111/dme.12542
  39. Wang K-S, Wang L, Zheng S, Wu L-Y. Associations of smoking status and serious psychological distress with chronic obstructive pulmonary disease. Int J High Risk Behav Addict. 2013;2:59–65. doi:10.5812/ijhrba.10333
  40. Park H, Jung SY, Lee K, et al. Prevalence of chronic obstructive lung disease in Korea using data from the Fifth Korea National Health and Nutrition Examination Survey. Korean J Fam Med. 2015;36:128–134. doi:10.4082/kjfm.2015.36.3.128
  41. Clair C, Meigs JB, Rigotti NA. Smoking behavior among US adults with diabetes or impaired fasting glucose. Am J Med. 2013;126:541.e15–8. doi:10.1016/j.amjmed.2012.11.029
  42. Polakowska M, Kwaśniewska M, Szcześniewska D, et al. Nałóg palenia tytoniu w populacji polskiej. Wyniki programu WOBASZ. Kardiol Pol. 2005;63:S1–5.
  43. Völzke H, Ittermann T, Schmidt CO, et al. Prevalence trends in lifestyle-related risk factors. Dtsch Ärztebl Int. 2015;112:185–192. doi:10.3238/arztebl.2015.0185
  44. Karam C, Beauchet A, Czernichow S, et al. Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated French urban population: The CARVAR 92 study. PloS One. 2015;10:e0124817. doi:10.1371/journal.pone.0124817
  45. Perez-Rios M, Fernandez E, Schiaffino A, Nebot M, Lopez MJ. Changes in the prevalence of tobacco consumption and the profile of Spanish smokers after a comprehensive smoke-free policy. PLOS One. 2015;10:e0128305. doi:10.1371/journal.pone.0128305
  46. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2014 update: A report from the American Heart Association. Circulation. 2014;129:e28–292. doi:10.1161/01.cir.0000441139.02102.80
  47. Romundstad P, Janszky I, Vatten L, et al. Cancer risk factors in Poland: The PONS Study. Ann Agric Environ Med. 2011;18:251–254.
  48. Korhonen P, Vesalainen R, Aarnio P, Kautiainen H, Järvenpää S, Kantola I. Assessment of cardiovascular risk in primary health care. Scand J Prim Health Care. 2012;30:101–106. doi:10.3109/02813432.2012.675564
  49. Dorobantu M, Bădilă E, Ghiorghe S, Darabont RO, Olteanu M, Flondor P. Total cardiovascular risk estimation in Romania. Data from the SEPHAR study. Rom J Intern Med. 2008;46:29–37.
  50. Vikhireva O, Pajak A, Broda G, et al. SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results. Eur Heart J. 2014;35:571–577. doi:10.1093/eurheartj/eht189
  51. Shang X, Li J, Tao Q, et al. Educational level, obesity and incidence of diabetes among Chinese adult men and women aged 18–59 years old: An 11-Year follow-up study. PLoS One. 2013;8:e66479. doi:10.1371/journal.pone.0066479
  52. Strazzullo P, D’Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: Meta-analysis of prospective studies with 2 million participants. Stroke. 2010;41:e418–26. doi:10.1161/STROKEAHA.109.576967
  53. Hanson C, Rutten E, Wouters EFM, Rennard S. Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:723–733. doi:10.2147/COPD.S50111
  54. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–229. doi:10.1001/archgenpsychiatry.2010.2
  55. Ogunmola OJ, Olaifa AO, Oladapo OO, Babatunde OA. Prevalence of cardiovascular risk factors among adults without obvious cardiovascular disease in a rural community in Ekiti State, Southwest Nigeria. BMC Cardiovasc Disord. 2013;13:89. doi:10.1186/1471–2261–13–89
  56. Lee JW, Lim NK, Baek TH, Park SH, Park HY. Anthropometric indices as predictors of hypertension among men and women aged 40–69 years in the Korean population: The Korean Genome and Epidemiology Study. BMC Public Health. 2015;15:140. doi:10.1186/s12889–015–1471–5
  57. An Y, Yi S, Fitzpatrick A, et al. Appropriate body mass index and waist circumference cutoff for overweight and central obesity among adults in Cambodia. PloS One. 2013;8:e77897. doi:10.1371/journal.pone.0077897
  58. Asiki G, Murphy GAV, Baisley K, et al. Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: A community based survey. PLOS One. 2015;10:e0126166. doi:10.1371/journal.pone.0126166
  59. Cerhan JR, Moore SC, Jacobs EJ, et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89:335–345. doi:10.1016/j.mayocp.2013.11.011
  60. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi:10.1186/1471–2458–9-88
  61. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
  62. Esposito K, Kastorini C-M, Panagiotakos DB, Giugliano D. Prevention of type 2 diabetes by dietary patterns: A systematic review of prospective studies and meta-analysis. Metab Syndr Relat Disord. 2010;8:471–476. doi:10.1089/met.2010.0009
  63. Sygnowska E, Waśkiewicz A, Głuszek J, et al. Spożycie produktów spożywczych przez dorosłą populację Polski. Wyniki programu WOBASZ. Kardiol Pol. 2005;63:S1–7.
  64. Leon DA, Shkolnikov VM, Borinskaya S, et al. Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: Evidence from two population-based studies. Eur J Epidemiol. 2013;28:393–404. doi:10.1007/s10654–013–9808–9
  65. Waśkiewicz A, Sygnowska E. Alcohol intake and cardiovascular risk factor profile in men participating in the WOBASZ study. Kardiol Pol. 2013;71:359–365.
  66. Kim JY, Lee DY, Lee YJ, et al. Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction. World J Biol Chem. 2015;6:1–15. doi:10.4331/wjbc.v6.i1.1
  67. Kiejna A, Piotrowski P, Adamowski T, et al. The prevalence of common mental disorders in the population of adult Poles by sex and age structure – An EZOP Poland study. Psychiatr Pol. 2015;49:15–27. doi:10.12740/PP/30811
  68. Poulsen K, Cleal B, Clausen T, Andersen LL. Work, diabetes and obesity: A seven year follow-up study among Danish health care workers. PLoS One. 2014;9:e103425. doi:10.1371/journal.pone.0103425
  69. Daniele TM da C, Bruin VMS de, Oliveira DSN de, Pompeu CMR, Forti ACE. Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes. Arq Bras Endocrinol Metabol. 2013;57:44–50.
  70. Drygas W, Sakłak W, Kwaśniewska M, et al. Epidemiology of physical activity in adult Polish population in the second decade of the 21st century. Results of the NATPOL 2011 study. Int J Occup Med Environ Health. 2013;26:846–855. doi:10.2478/s13382–013–0160–9
  71. Biernat E, Tomaszewski P. Association of socio-economic and demographic factors with physical activity of males and females aged 20–69 years. Ann Agric Environ Med. 2015;22:118–123. doi:10.5604/12321966.1141380
  72. Garfield LD, Scherrer JF, Hauptman PJ, et al. Association of anxiety disorders and depression with incident heart failure. Psychosom Med. 2014;76:128–136. doi:10.1097/PSY.0000000000000027
  73. Piwoński J, Piwońska A, Sygnowska E. Is there an association between depressive symptoms and coronary artery disease in the Polish adult population? Kardiol Pol. 2014;72:50–55. doi:10.5603/KP.a2013.0149
  74. Choi NG, Kim J, Marti CN, Chen GJ. Late-life depression and cardiovascular disease burden: Examination of reciprocal relationship. Am J Geriatr Psychiatry. 2014;22:1522–1529. doi:10.1016/j.jagp.2014.04.004
  75. van Marwijk HWJ, van der Kooy KG, Stehouwer CDA, Beekman ATF, van Hout HPJ. Depression increases the onset of cardiovascular disease over and above other determinants in older primary care patients, a cohort study. BMC Cardiovasc Disord. 2015;15:40. doi:10.1186/s12872–015–0036-y
  76. Cooper DC, Trivedi RB, Nelson KM, et al. Sex differences in associations of depressive symptoms with cardiovascular risk factors and metabolic syndrome among African Americans. Cardiovasc Psychiatry Neurol. 2013;2013:979185. doi:10.1155/2013/979185
  77. Gillen G. Coping during inpatient stroke rehabilitation: An exploratory study. Am J Occup Ther. 2006;60:136–145.
  78. Klein DM, Turvey CL, Pies CJ. Relationship of coping styles with quality of life and depressive symptoms in older heart failure patients. J Aging Health. 2007;19:22–38. doi:10.1177/0898264306296398
© Wroclaw Medical University